RituximabCOVID-19 pneumonia

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2024年 / 2017卷 / 1期

关键词：

D O I：

10.1007/s40278-024-63415-4

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：439 / 439

相关论文

共 50 条

[31] RituximabCOVID-19 infection: case report
Reactions Weekly, 2022, 1928 (1) : 324 - 324
[32] RituximabCOVID-19: 2 case report
Reactions Weekly, 2021, 1870 (1) : 281 - 281
[33] Prednisolone/RituximabCOVID-19 pneumonia, rebound effect of COVID-19 pneumonia and off-label use
Reactions Weekly, 2024, 2019 (1) : 394 - 394
[34] COVID-19-vaccines/prednisolone/rituximabCOVID-19 pneumonia and lack of efficacy: case report
Reactions Weekly, 2022, 1925 (1) : 190 - 190
[35] RituximabCOVID-19 infection: 3 case reports
Reactions Weekly, 2021, 1846 (1) : 283 - 283
[36] Cyclophosphamide/rituximabCOVID-19 infection: case report
Reactions Weekly, 2021, 1885 (1) : 170 - 170
[37] RituximabCOVID-19 infection: 2 case reports
Reactions Weekly, 2022, 1897 (1) : 324 - 324
[38] RituximabCOVID-19 infection: 8 case reports
Reactions Weekly, 2021, 1872 (1) : 440 - 440
[39] RituximabCOVID-19 infection: 2 case reports
Reactions Weekly, 2020, 1833 (1) : 342 - 342
[40] RituximabCOVID-19 respiratory infection: 9 case reports
Reactions Weekly, 2021, 1863 (1) : 301 - 301

← 1 2 3 4 5 →